A Phase 2, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Sotaterceptversus Placebo for the Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension(Cpc-PH) due to Heart Failure with Preserved Ejection

Project: Research project

Project Details

Description

A Phase 2, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Sotatercept versus Placebo for the Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension (Cpc-PH) due to Heart Failure with Preserved Ejection
StatusActive
Effective start/end date9/1/219/30/25

Funding

  • ACCELERON PHARMA INC.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.